entinostat,atezolizumab
roche,kyowa kirin,syndax pharmaceuticals
['sclc', 'lung', 'atezo', 'entinostat']
#asco22 publication discusses findings from #etctn (10399), phase i study , testing entinostat in combination with atezolizumab, carboplatin and etoposide for the treatment of previously untreated aggressive #lungcancer disease. #sclc . more: 
Official Twitter account of the NCI Cancer Therapy Evaluation Program, providing updates to our trials research community. Privacy: https://t.co/47s9FxzVVe.